CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday

Benzinga·06/12/2025 14:50:53

Listen to the news

U.S. stocks were higher, with the Dow Jones index gaining around 0.1% on Thursday.

Shares of CureVac N.V. (NASDAQ:CVAC) rose sharply during Thursday's session after BioNTech announced it will acquire the company in an all-stock transaction.

CureVac shares jumped 38% to $5.61 on Thursday.

Here are some other big stocks recording gains in today’s session.

TELUS International (Cda) Inc. (NASDAQ:TIXT) gained 20.6% to $3.57 after the company announced it proposed the acquisition of TELUS Digital to accelerate AI and SaaS transformation across core business sectors.
Fortrea Holdings Inc. (NASDAQ:FTRE) jumped 15% to $6.25. Fortrea adopted limited-duration stockholder rights plan.
Oracle Corporation (NYSE:ORCL) gained 13.7% to $200.65 after the company reported better-than-expected quarterly financial results and issued upbeat outlook commentary.
Hippo Holdings Inc. (NYSE:HIPO) rose 13.1% to $30.64. The Baldwin Group entered into agreement to acquire Homebuilder Distribution Network from Hippo.
USA Rare Earth, Inc. (NASDAQ:USAR) climbed 12.8% to $14.05.
DeFi Development Corp. (NASDAQ:DFDV) gained 11.7% to $29.34. The company announced it secured a $5 billion equity facility with RK Capital.
Yuanbao Inc. (NASDAQ:YB) rose 11.7% to $17.58.
TransAlta Corporation (NYSE:TAC) gained 7.4% to $11.25. Jefferies analyst Julien Dumoulin-Smith upgraded TransAlta from Hold to Buy and raised the price target from C$12 to C$20.
Genius Sports Limited (NYSE:GENI) rose 6.5% to $10.28. Texas Capital Securities analyst David Bain initiated coverage on Genius Sports with a Buy rating and announced a price target of $14.
BeOne Medicines Ltd. (NASDAQ:ONC) rose 6% to $277.93 after the company announced that the FDA approved a new tablet formulation of BRUKINSA for all five approved indications.

Now Read This:

Top 2 Defensive Stocks That May Keep You Up At Night In Q2

Photo via Shutterstock

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English